← Back to Search

Procedure

Bachmann's bundle area pacing for Atrial Fibrillation

N/A
Waitlist Available
Research Sponsored by University of Vermont
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up over 15 month follow up
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new way to place pacemaker leads in the heart to help patients with irregular heartbeats. The leads are placed using both X-ray and electrical signals to ensure they are in the best spot. The goal is to see if this method works better than the usual way of placing leads.

Eligible Conditions
  • Atrial Fibrillation

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~over 15 month follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and over 15 month follow up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Atrial arrhythmia burden from pacemaker counters
Secondary study objectives
Atrial Fibrillation Severity Scale Version 2.0
EQ-5D-3L survey (*EQ-5D-3L is the name of the instrument and is not an acronym)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Bachmann's bundle area pacingExperimental Treatment1 Intervention
Lead placement in Bachmann's bundle area
Group II: Right atrial appendage pacingActive Control1 Intervention
Lead placement in the right atrial appendage

Find a Location

Who is running the clinical trial?

University of VermontLead Sponsor
277 Previous Clinical Trials
3,744,034 Total Patients Enrolled
2 Trials studying Atrial Fibrillation
54 Patients Enrolled for Atrial Fibrillation
~18 spots leftby Nov 2025